Drug profile · INN
iothalamate sodium
ANGIO-CONRAY
iothalamate sodium (ANGIO-CONRAY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Drug details — iothalamate sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
iothalamate sodium (ANGIO-CONRAY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is iothalamate sodium?
iothalamate sodium (ANGIO-CONRAY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for iothalamate sodium?
ANGIO-CONRAY is a marketed brand name for iothalamate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iothalamate sodium?
iothalamate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.